2023 annual financial data
AnaptysBio 2023 Net margin
Direct answer
Net margin was -953.66%.
Operating income was -164,411,000 USD and net income was -163,619,000 USD.
Operating cash flow was -120,800,000 USD.
Get free AnaptysBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,157,000 USD
- Operating income
- -164,411,000 USD
- Net income
- -163,619,000 USD
- Operating cash flow
- -120,800,000 USD